S121: REDUCED RATE OF VASO-OCCLUSIVE CRISES (VOCS) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) TREATED WITH CRIZANLIZUMAB FOR 12 MONTHS: RESULTS FROM A REAL-WORLD, MANAGED ACC...

por Silva-Pinto, A, Colombatti, R, Pasanisi, A, Arcioni, F, DeBonnett, L, Soliman, W, Sarkar, R, Cançado, R
Publicado 2022

P1491: REAL-WORLD INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB: RESULTS FROM A MANAGE...

por Silva-Pinto, A. C., Colombatti, R., Pasanisi, A., Arcioni, F., DeBonnett, L., Soliman, W., Sarkar, R., Cançado, R. D.
Publicado 2022

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SUR...

por Osunkwo, I, Andemariam, B, Minniti, C, El Rassi, F, Nur, E, Nero, A, Colombatti, R, de Montalembert, M, Abboud, M, Arlet, J, Jain, S, Jastaniah, W, Pita, M, Trimnell, C, DeBonnett, L, Bailey, T, Rajkovic-Hooley, O, Inusa, B, James, J
Publicado 2022

P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESS...

por Andemariam, B., James, J., Minniti, C., Inusa, B., El Rassi, F., Nero, A., Trimnell, C., Abboud, M. R., Arlet, J.-B., Colombatti, R., de Montalembert, M., Jain, S., Jastaniah, W., Nur, E., Pita, M., DeBonnett, L., Bailey, T., Rajkovic-Hooley, O., Osunkwo, I.
Publicado 2022